EyePoint (EYPT) Cash & Equivalents (2010 - 2026)

EyePoint (EYPT) has 17 years of Cash & Equivalents data on file, last reported at $77.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 8.74% year-over-year to $77.7 million; the trailing twelve-month figure through Mar 2026 stood at $77.7 million (down 8.74% YoY), and the FY2025 full-year result was $101.8 million, up 2.12% from the prior year.
• Cash & Equivalents retreated to $77.7 million in Q1 2026, from $101.8 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $281.3 million in Q4 2023 to a low of $71.1 million in Q2 2025.
• A 5-year average of $115.7 million and a median of $95.6 million in 2022 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents jumped 194.11% in 2023 and sank 68.58% in 2025, its largest moves.
• Tracing EYPT's Cash & Equivalents over 5 years: stood at $95.6 million in 2022, then soared by 194.11% to $281.3 million in 2023, then slumped by 64.55% to $99.7 million in 2024, then rose by 2.12% to $101.8 million in 2025, then slipped by 23.68% to $77.7 million in 2026.
• Business Quant data shows EYPT's Cash & Equivalents at $77.7 million in Q1 2026, $101.8 million in Q4 2025, and $74.6 million in Q3 2025.